Avanzanite
Amsterdam, NL · 1 known investors
Find your way into Avanzanite
Sign up to find every way you can get introduced to Avanzanite
- Your email: who you already know at Avanzanite, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Avanzanite team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Avanzanite is a biopharmaceutical commercialization and distribution company that partners with emerging research-based drug originators to license and distribute approved orphan (rare disease) medicines across European markets. It operates as an authorized wholesaler within the European Economic Area, aiming to expand patient access to rare disease treatments across 30+ European countries.
Founders & leadership
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ANov 2025 · 3 sources
MVM Partners (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Avanzanite do?
- Avanzanite is a biopharmaceutical commercialization and distribution company that partners with emerging research-based drug originators to license and distribute approved orphan (rare disease) medicines across European markets. It operates as an authorized wholesaler within the European Economic Area, aiming to expand patient access to rare disease treatments across 30+ European countries.
- Who founded Avanzanite?
- Avanzanite was founded by Adam Plich, Anant Murthy.
- Who are Avanzanite's investors?
- Avanzanite's investors include MVM Life Science Partners.
- Where is Avanzanite headquartered?
- Avanzanite is headquartered in Amsterdam, NL.

